Teleflex to Present at the 39th Annual J.P. Morgan Healthcare Conference
Teleflex, a global medical technology provider, announced that its Chairman and CEO, Liam Kelly, will present at the 39th Annual J.P. Morgan Healthcare Conference on January 12, 2021, at 8:20 a.m. ET. An audio webcast and slide presentation will be accessible on the investor section of the Teleflex website. Teleflex focuses on innovative healthcare solutions in various fields, including vascular access, anesthesia, and emergency medicine, aiming to improve the lives of patients and healthcare providers.
- None.
- None.
WAYNE, Pa., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the 39th Annual J.P. Morgan Healthcare Conference on Tuesday, January 12, 2021 at 8:20 a.m. (ET).
A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia, emergency medicine, surgical, urology and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rüsch®, UroLift®, and Weck® – trusted brands united by a common sense of purpose.
Source:
Teleflex Incorporated
Jake Elguicze
Treasurer and Vice President, Investor Relations
610-948-2836
FAQ
When will Teleflex's CEO speak at the J.P. Morgan Healthcare Conference?
Where can I watch the Teleflex presentation from the J.P. Morgan Healthcare Conference?
What are the key areas of focus for Teleflex's medical technologies?